TERMS
LAB VALUES
NURSING PROCESS
PHARMACOKINETICS
DRUG EFFECTS
SAFETY
200

Non-proprietary name which identifies the drug's active ingredient

Generic name

200

AST & ALT are used to measure this

Liver function (LFTs)

200

Role of the nurse when intervening on a patient's behalf

Advocate

200

Fastest parenteral route of absorption

Intravenous (IV)

200

Consuming grapefruit juice inhibits this

Cytochrome P-450 system

200

Information regarding any serious, life-threatening adverse effect

Black Box Warning

400

Hypersensitivity to a drug

Allergic reaction

400

BUN is the abbreviation

Blood urea nitrogen

400

Actual or potential problems requiring intervention by the nurse

Nursing diagnosis

400

Administering medications through a nasogastric (NG) tube is an example of this route

Enteral

400

Drug with a 1/2 life of 2 hours and current serum level of 20mg/dL will take this long to reach 5mg/dL

4 hours

400

Jaundice and elevated liver enzymes in response to a drug indicates this

Hepatotoxicity

600

Response which occurs when an individual reacts in a unique manner to a drug that is not usual or predicted

Idiosyncratic response

600

Serum level specific to renal function

Creatinine

600

Comparing the desired outcome with the actual outcome

Evaluation

600

These drugs easily penetrate cell walls and are more likely to cross the blood-brain barrier

Lipid soluble

600

Two unlike drugs together create a greater effect than either alone (1+1=3)

Synergistic effect

600

Significant rise in BUN & creatinine after drug administration most likely indicates this

Nephrotoxicity

800

Measure of the extent of drug absorption for a given drug & route

Bioavailability

800

Value included in the CBC which indicates oxygen-carrying capability

Hemoglobin (Hgb)

800

Labs and diagnostic tests are part of this phase of the nursing process

Assessment

800

Result of first-pass effect

Little to no active drug sent to general circulation

800

One drug blocks the effect of the other

Antagonistic effect

800

Bone marrow suppression as a result of drug administration

Blood dyscrasia

1000

Condition under which a drug should not be used

Contraindication

1000

Used to monitor warfarin (Coumadin) therapy and also used to look at potential liver damage

PT/INR

1000

Two of the four criteria which must be included when setting goals/outcomes for a patient

Specific

Measurable

Realistic

Time-framed

1000

If a highly protein-bound drug is given to a patient with an albumin of 1.6, this may result.

Drug toxicity

1000

Maintenance of desired drug level (in=out)

Steady state

1000

Characterized by difficulty breathing, increased HR, panic, and low BP

Anaphylaxis

M
e
n
u